ScienceDaily (Aug. 16, 2010) — A study led by a researcher at Albert Einstein College of Medicine of Yeshiva University has revealed a unique “partnership” between two types of bone marrow stem cells, which could lead to advances in regenerative medicine. The study was led by Paul Frenette, M.D., the new director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research at Einstein. Dr. Frenette conducted the research while at Mt. Sinai School of Medicine in New York City. The research was published in the Aug 12 issue of Nature.
Scientists have discovered an accomplice in breast cancer — a master control switch with the power to set off a cascade of reactions orchestrated by an oncogene named Wnt1. This executive molecule and its modus operandi are reported in back-to-back papers featured on the cover of the August 15 issue of Cancer Research.
Duke University physicists have developed a way to produce sharp fluid jets with enough precision that they can inject material into a single, living cell. The technique promises a way to deliver drugs to cells one at a time, which is likely to be very valuable for research involving stem cells and other cellular-level studies. The research appears in the current issue of the APS journal Physical Review Letters.
ScienceDaily (Aug. 17, 2010) — Men and yeast have something in common: they use the same molecular process to ensure the integrity of their gene pool during reproduction. This is a recent finding by researchers from CNRS, Inserm and the Université Joseph Fourier in Grenoble, whose scientists are studying yeast in order to shed light on the numerous cases of male infertility related to the malfunction of this process during spermatogenesis.
Over the last fifty years, male fertility has declined steadily. Men are thought to have lost half their spermatozoa in half a century, probably because of pollutants. But the fragility of the remaining spermatozoa is also responsible for this situation. Read the research on the functional dynamics of histones in gametogenesis in Genes and Development.
NEW YORK (GenomeWeb News) – A new research consortium led by the Salk Institute of Biological Studies and the Sanford-Burnham Medical Research Institute will use a $21 million grant from the National Institutes of Health to conduct systems biology-based studies of the earliest immune system responses to HIV infection.
The multidisciplinary research effort will include DNA sequencing, expression analysis, RNAi analysis, mass spectrometry, and other efforts aimed at discovering the cellular protein mechanisms that are the first line of defense against HIV.
Along with Salk and Sanford-Burnham, the research program will fund research at the University of California, San Francisco; Mount Sinai School of Medicine; the University of California, San Diego; Northwestern University; and the University of Pennsylvania.
“The events that occur immediately after exposure to HIV, which determines the ability of the virus to establish infection and ultimately shape the course of the disease, are very poorly understood,” Sumit Chanda, an adjunct professor at the Salk Institute, said in statement.
“This grant funds a multi-center consortium that will integrate cutting edge technologies in systems biology and next-generation sequencing, with world-leading expertise in immunology and virology to decode and model the early molecular events that occur after HIV enters the body,” Chanda added. “These projects will be fundamental towards the development of safe and effective HIV vaccines, as well as novel preventative therapies for HIV.”
The research will include next-generation sequencing focused on identifying relevant polymorphisms at Northwestern University, microarray expression analysis at Burnham and Mount Sinai, high-throughput affinity purification mass-spec approaches at UCSF, and large-scale RNAi analysis projects at Sanford-Burnham, Chanda told GenomeWeb Daily News in an e-mail.